2-methyl-1-(2-(5-(p-tolyl)-1H-imidazol-2-yl)piperidin-1-yl)butan-1-one
At a glance
No summary yet, this entry is part of a bulk import from the IFRA Transparency List and hasn't been individually written up.
Why synthetics aren't a downgrade, a different toolkit โ ยท Why some materials get IFRA-restricted โ